Biotech · Public company · Newtown, PA, US
Traws Pharma, Inc.
Ticker TRAW · SEC CIK 0001130598
Track this companyFree. Adds Traws Pharma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials110 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline12
- Any approved or standard-of-care therapyPhase 3 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- best supportive care (BSC)Phase 3 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ON 01910.NaPhase 3 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- rigosertibPhase 3 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- rigosertib sodiumPhase 3 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- AzacitidinePhase 2 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Letrozole 2.5mgPhase 2 · Endometrioid Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- NarazaciclibPhase 2 · Endometrioid Endometrial CancerClinicalTrials.gov · fetched Nov 12, 2026
- oral rigosertibPhase 2 · Myelodysplastic SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- Oral rigosertibPhase 2 · Myelodysplastic SyndromesClinicalTrials.gov · fetched Nov 12, 2026
- briciclibPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- ON123300Phase 1 · Solid Tumors, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic MalignanciesPHASE1_PHASE2 · UNKNOWN · started Mar 29, 2023ClinicalTrials.gov NCT05705505 · fetched Nov 12, 2026
- Rigosertib in Patients With Recessive Dystrophic Epidermolysis Bullosa Associated SCCEARLY_PHASE1 · COMPLETED · started Aug 24, 2021ClinicalTrials.gov NCT04177498 · fetched Nov 12, 2026
- Study of ON 123300 in Patients With Advanced CancerPHASE1 · UNKNOWN · started May 13, 2021ClinicalTrials.gov NCT04739293 · fetched Nov 12, 2026
- Rigosertib Plus Nivolumab for KRAS+ NSCLC Patients Who Progressed on First-Line TreatmentPHASE1_PHASE2 · COMPLETED · started Jun 29, 2020ClinicalTrials.gov NCT04263090 · fetched Nov 12, 2026
- Controlled Study of Rigosertib Versus Physician's Choice of Treatment in MDS Patients After Failure of an HMAPHASE3 · TERMINATED · started Dec 2, 2015ClinicalTrials.gov NCT02562443 · fetched Nov 12, 2026
- Dose-escalation, Safety and Pharmacokinetic Study of Briciclib in Advanced Solid TumorsPHASE1 · TERMINATED · started Jun 1, 2014ClinicalTrials.gov NCT02168725 · fetched Nov 12, 2026
- Three Dosing Schedules of Oral Rigosertib in MDS PatientsPHASE1 · WITHDRAWN · started May 1, 2014ClinicalTrials.gov NCT02075034 · fetched Nov 12, 2026
- Phase II Part 2 Expansion of Oral Rigosertib in Combination With AzacitidinePHASE1_PHASE2 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01926587 · fetched Nov 12, 2026
- Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or DecitabinePHASE3 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01928537 · fetched Nov 12, 2026
- Oral Rigosertib in Low Risk MDS Patients Refractory to ESAsPHASE2 · COMPLETED · started Jul 1, 2013ClinicalTrials.gov NCT01904682 · fetched Nov 12, 2026
- Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess BlastsPHASE3 · COMPLETED · started Nov 1, 2010ClinicalTrials.gov NCT01241500 · fetched Nov 12, 2026
SEC filings12
- S-1 · FORM S-1SEC EDGAR · filed Oct 26, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 23, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 14, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 31, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 10, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jul 9, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 22, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 12, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 27, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 26, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 15, 2026 · fetched Nov 12, 2026